been reported to increase in sputum from COPD patients, we hypothesized that inhibiting SphK1 will decrease S1P synthesis and attenuates NE-induced airway inflammation.
1 inhibitor (SK1-I) (5 mg/kg in PBS) was administered intranasally into C57BL/6 mice 1 h before NE administration. Bronchoalveolar lavage fluid (BALF) and lung sections were analyzed on day 11. We measured total cell counts and S1P secretion in BALF. We also evaluated the effect of SK1-I on airway inflammation and goblet cells by determining the Alcian blue/PAS-positive area in lung sections (evaluated by a semiautomatic imaging system, WinROOF ® (Mitani corporation, Japan)).
Results: NE increased total cell number (9.3 AE .75×10-4 vs 51.5 AE 1.1×10-4 per mL, P < 0.01) and neutrophil count (0.0 AE .04×10 − 4 vs 34. AE 2.7 × 10 − 4 per mL, P < 0.001) in BALF, and induced airway goblet cell hyperplasia. NE also increased S1P secretion (P < 0.05) in BALF. Treatment with SK1-I inhibited NE-induced increase of total cell numbers (13. AE .73×10-4 per mL, P < 0.05), neutrophil count (2.6 AE .28×10-4 per mL, P < 0.01), and KC (P < 0.01) in BALF. SK1-I attenuated NE-induced goblet cell hyperplasia.
Conclusion:
Inhibiting SphK1 caused significant reduction in NEinduced neutrophilic airway inflammation and goblet cell hyperplasia in mice. Our results suggest that the inhibition of S1P signalling could be a new therapeutic strategy for COPD. Flos Magnoliae (FM, Chinese name: Xin-yi) is an oriental medicinal herb commonly used for symptomatic relief of upper airway disease. In this study, we examined the effects of FM extract and its chemical constituents on the modulation of ANO1 channels to evaluate for use in therapeutic agents for treatment of asthma.
Methods: A 30% ethanolic extract of FM was prepared. Human ANO1 over-expressed HEK293T cells were treated with FM extract or its five chemical constituents. Modulation of ANO1 activity was measured by using a conventional whole-cell patch-clamp technique.
Results: We revealed that FM EtOH (30, 100, and 300 μg/mL) and its chemical constituent tiliroside inhibited ANO1 activity in ANO1-overexpressing HEK293T cells. In addition, we showed that the treatment of airway epithelial cell line Calu-3 with interleukin-4 significantly increased ANO1 current (I ANO1 ), but not cystic fibrosis transmembrane conductance regulator (CFTR)-mediated chloride current (I CFTR ). FMEtOH and tiliroside specifically modulated I ANO1 .
Our results suggest that FM extract and its chemical constituent, tiliroside, may have a therapeutic potential for respiratory inflammatory disease through modulating the activities of ANO1. Background and Aims: Chronic systemic inflammation is a pathogenetic mechanism underlying airway obstruction and most systemic manifestations in COPD and asthma. Chronic airway inflammation is regulated by a complex network of systemic mediators.
Aim: To establish the role of mediators of the immune, endocannabinoid, lipoxygenase and nitroxidergic systems in the regulation of inflammation in moderate and severe COPD and controlled asthma.
Methods: Flow cytometry, gas-liquid chromatography, enzyme immunoassay.
Results: A commonality of immune disorders in COPD and asthma has found. It has revealed that T helper (Th) immune response depending on the disease severity or the disease control is multi-type. The mixed phenotypes appear and it is followed by development Th17 type of immune response associated with the disease progression. The common mechanisms of maintenance of systemic inflammation also include a decrease in the expression of cannabinoid receptors type 2 (CB2), an increase in the synthesis of nitric oxide, a hyperproduction of cytotoxic eicosanoids that is a result of metabolic changes in fatty acids (FA), an imbalance between their pro-and antiinflammatory oxy derivatives. The substantial reorganization of FA composition of mitochondrial membrane is a sign of mitochondrial dysfunction determining the formation of the hypoxia. The endocannabinoid system and its receptors play a special role in the inflammation control. The increased CB2 expression contributes keeping the balance between pro-and antiinflammatory mediators under normal conditions. Inhibition of CB2 expression induces limiting the function of endocannabinoid system, which leads to the immune system activation. The correlation between the level of nitric oxide and the pathological process severity indicate that the dysfunction of nitroxidergic system make a contribution to the development of the respiratory diseases.
The obtained knowledge broadens our understanding of the etiopathogenesis of respiratory diseases and also can explain the key mechanisms of the development of extrapulmonary pathology induced by the chronic inflammatory process. Background and Aims: Ventilator induced lung injury (VILI) confers significant sequelae of mechanical ventilation in critical care, and lung protection strategy had been developed. However, the impact of obesity on ventilator induced lung injury is not fully understood. One recent search found fat-fed mice significantly attenuated ventilator-induced lung injury. Alevolar macrophages (AMs) is known to be pivotal in initiating acute lung injury. In the present study, we supposed that the obesity may affect the polarization of AMs and subsequent development of acute lung injury.
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